INSTRUCTION TO AUTHORS
Instruction to Authors
Introduction:
Journal
of
Pharmaceutical
Science
and
Bioscientific
Research
is
an
international
open
access
journal
that
publishes
innovative
papers,
reviews,
rapid
communications
and
notes
dealing
with
field
of
Pharmacy
and
Pharmaceutical
Science.
Areas
of
particular
interest
include:
Pharmaceutical
Technology,
Novel
Drug
Delivery,
Biopharmaceutics,
Pharmacokinetics,
Pharmaceutical
Analysis,
Medicinal
Chemistry,
Clinical
and
Hospital
Pharmacy,
Pharmacognosy
and
Phytochemistry,
Pharmacology,
Bioinformatics
and
Biotechnology,
Cell
Biology,
Genomic
and
Proteomics,
Genetics
Quality
Assurance
and
Pharmaceutical
Regulatory
Affairs,
Pharmaceutical
Regulatory Affairs, Pharmaceutical Regulatory Affairs and Pharma Management of Pharmaceutical Interest.
Before You Begin:
All
submitted
manuscripts
should
contain
original
work
neither
published
previously
not
under
consideration
for
publication
elsewhere.
Articles
from
any
part
of
the
world
are
accepted
provided
submitted
in
English
language
only.
Page
limit
for
Research
article
and
for
Review
article
is
15-20
pages.
Authors,
in
their
cover
letter
to
Editor,
should
clearly
mention
whether
the
manuscript
is
to
be
considered
as
a
Research
or
a
Review
article.
In
case
of
Review article, should include current topics on the subject of general interest.
It
is
necessary
that
authors
prepare
their
manuscripts
according
to
the
instructions.
Effectiveness
of
the
peer
review process will greatly depends upon the care used by the authors in preparing the manuscripts.
Authors
must
state
in
a
covering
letter
when
submitting
papers
for
publication
the
novelty
embodied
in
their work or in the approach taken in their research.
Cover letter sample is given at web site
www.jpsbr.org
If any query arises please contact
at
jpsbronline@rediffmail.com
or at website
www.jpsbr.org
Peer Review Process:
All
manuscripts
receive
individual
identification
codes.
The
Editor
in
Chief
then
sends
it
to
a
proper
editor.
The
editors
are
fully
responsible
for
decisions
about
manuscripts.
The
final
decision
whether
to
accept
or
to
reject
manuscript
rests
with
editors.
Editor
in
Chief
only
communicates
the
final
decision
and
informs
about
the
further
processing.
Pagiarism: Manuscript will be considered for publication if having plagiarism <10%
Revised Manuscript Submission:
Whenever
revision
of
a
manuscript
is
needed,
authors
should
return
the
revised
version
of
their
manuscripts
as
early as possible. This will help them for rapid processing for further.
Transfer of Copy right Agreement:
Transfer
of
Copyright
Agreement
must
be
provided
for
each
accepted
manuscript
and
that
should
be
dully
signed,
scanned and sent via mail to the Editor in Chief.
Download the copyright form from
here
Formats of manuscript
The
following
sections
are
required
and
should
be
arranged
in
the
following
order:
Cover
Letter,
Manuscript
[Title
page,
Abstract,
Keywords,
1.
Introduction,
2.
Materials
and
methods,
3.
Results
and
discussion,
4.
Conclusion, (Acknowledgements), References, Figure and Table with legends].
Prepare
Manuscript
in
Calibri
font
using
font
size
of
12
with
normal
margins
on
all
the
sides.
Title
shall
be
in
a
font
size
14,
bold
face
capitals.
All
section
titles
shall
be
in
font
size
12,
bold
face
capitals.
Pages
should
be
numbered
consecutively.
Subtitles
in
every
section
shall
be
in
font
size
12,
bold
face
lower
case.
Standard
International
Units
should be used through the text.
Manuscripts
should
be
submitted
as
per
order:
Title
Page,
Abstract,
Key
words,
Introduction,
Material
and
Methods,
Results, Discussion and References.
Title Page
The
title
should
be
as
short
as
possible
and
precisely
indicate
the
nature
of
the
work
in
the
communication.
Names
of
the
authors
should
appear
as
initials
followed
by
surnames
along
with
their
affiliation
to
the
workplace
(where
work
hasbeen
carriedout).
At
the
bottom
left
corner
of
the
title
page,
please
mention
“*For
Correspondence”
and
provide
a
functional
e-mail
address
of
corresponding
author
only.
If
any
of
the
co-authors
are
from
different
organizations, their addresses also be mentioned and indicated using numbers after their names.
Abstract
Should
be
started
on
new
page
after
the
title
page
and
it
should
not
exceed
250
words.
The
Abstract
should
be
informative and should state briefly the purpose of the research, the principal results and major conclusions.
Key words
:
5-7 key words must be given at the end of the abstract.
Introduction:
Should
starts
on
new
page.
This
part
should
define
the
background
and
significance
of
the
study
by
considering
the
relevant literature, particularly the most recent publications.
Materials and Methods
Please
provide
concise
but
complete
information
about
the
material
and
the
analytical,
statistical
and
experimental
procedures used. This part should be as clear to enable other scientists to repeat the research presented.
Results and Discussions
All
findings
presented
in
tabular
or
graphical
form
shall
be
described
in
this
section.
The
data
should
be
statistically
analysed
and
the
level
of
significance
stated.
Data
that
is
not
statistically
significant
need
only
to
be
mentioned
in
the
text
-
no
illustration
is
necessary.
All
Tables
and
figures
must
have
a
title
or
caption
and
a
legend
to
make
them
self-explanatory.
Discussion
must
be
written
with
reference
to
the
tables
and
figures
and
by
considering
information
from
the
literature
and
should
contain
a
short
review
of
the
results.
Any
Statements
made
in
the
any
above
sections
should
not be repeated here. There is no restriction for result and discussion to be written separately.
References
Should
be
numbered
consecutively
in
the
order
in
which
they
are
first
mentioned
in
the
text
(not
in
alphabetic
order).
Identify
references
in
text,
tables
and
legends
by
Arabic
numerals
in
superscript
in
square
brackets.
References
cited
only
in
tables
or
figure
legends
should
be
numbered
in
accordance
with
the
sequence
established
by the first identification in the text of the particular table or figure.
Examples:
Journals:
Shah
NM,
Fransis
R
and
Lesaly
RJ.
Synthesis
Characterization
and
Analytical
Studies
of
Adosupine,
Journal of Pharmacy Science, 2008; 134(5):1448-58.
Book:
Shah
Mamta
and
Marfatia
Sangeeta.
A
Text
Book
of
Pharmacognosy,
Nirav
&
Roopal
Publication,
Ahmedabad, First Edition. 2011:65-68.
Thesis:
Kaplan
SJ.
Posthospital
Home
Health
Care:
The
Elderly's
Access
and
Utilization
[dissertation].
St.
Louis
Washington University. 1995: 78-80.
Patent:
Kulkarni
N,
Kumar
LD
and
Sorg
A.
Fast
Dissolving
Orally
Consumable
Films
containing
an
Antitussive
and
a Mucosa Coating Agent, U.S. Patent 2003/206942, Nov 6, 2003.
Website:
Cartwright
J
(2007)
Big
stars
have
weather
too.
IOP
Publishing
Physics
Web
(http://physicsweb.org/Articles/news/11/6/16/1). Accessed 26 June 2015.
Tables and figures
Tables:
Each
table
must
be
given
on
a
separate
page
with
a
brief
but
complete
and
self
explanatory
caption
so
that
the
reader
can
easily
understand
the
results
presented
in
the
table.
Please
do
not
duplicate
material
that
is
already
presented in the figures.
Figures:
Photos
or
drawings
must
have
a
good
contrast
of
dark
and
light.
Legends
of
figures
should
be
brief,
but
complete
and
self-
explanatory
so
that
the
reader
can
easily
understand
the
results
presented
in
the
figure.
Please
do not duplicate material that is already presented in the tables.
Conflict of Interest statement
It must be declared by authors.
Galley Proof
Galley
proofs
would
be
sent
unless
indicated
otherwise
to
the
corresponding
author.
It
is
the
responsibility
of
the
corresponding
author
to
ensure
that
the
galley
proof
are
to
be
returned
without
delay
with
correction
(if
any).
The
authors are responsible for the contents appeared in their published manuscripts.
Ethical matter
Authors
using
experimental
animals
and
human
subjects
in
their
investigation
must
seek
approval
from
the
appropriate
Ethical
Committee.
The
method
section
must
include
a
statement
to
prove
that
the
investigation
was
approved
and
that
informed
consent
was
obtained.
Authors
have
to
submit
scan
copy
of
their
Approval
Certificate
as
an
attachment
via
jpsbronline@rediffmail.com
and
in
cover
note
they
have
to
mention
their
protocol
number.
Pagiarism in manuscript will lead to straight forward rejection for publication.
© JPSBR Publications 2011-2024
Powered by Opus